Avalo Therapeutics director June Almenoff acquires $12749 in stock - Investing.com
Avalo Therapeutics director June Almenoff acquires $12,749 in stock
Avalo Therapeutics
Business Services · Maryland, United States · <25 Employees
View Company Info for Free
About
Headquarters
540 Gaither Rd Ste 400, Rockville, Maryland, 20...Phone Number
(410) 522-8707Website
www.avalotx.comRevenue
<$5 MillionStock Symbol
AVTXIndustry
Most Recent Scoops
Aug 23 2024
Earnings
Aug 23 2024
Earnings
Highlights
$125.3M
Total Funding Amount
$27.5M
Most Recent Funding Amount
5
Number of Funding Rounds
Who is Avalo Therapeutics
Avalo Therapeutics is a global biopharmaceutical enterprise focused on the development and commercialization of products in Rare Pediatric and Orphan diseases. Cerecor is located in Rockville, Maryland.Read more
Avalo Therapeutics Org Chart
Is Avalo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Avalo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Avalo Therapeutics has new funding data
Product Launch: Get notified when Avalo Therapeutics launches new products
Earning: See what the market has to say on Avalo Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Avalo Therapeutics
Click to see if Avalo Therapeutics had a recent Job posting/layoffs
Check if Avalo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Avalo Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Avalo Therapeutics
Find 3 more new buyers
Compare Similar Companies to Avalo Therapeutics
Compare insights from companies similar to Avalo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Avalo Therapeutics
<$5M
-
Avalo Therapeutics financials insights
Gather financial insights about Avalo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Avalo Therapeutics Employee Growth Rate
View Avalo Therapeutics’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Avalo Therapeutics Tech Stack
A closer look at the technologies used by Avalo Therapeutics
See more technologies
Most Recent Scoops
Aug 23 2024
Earnings
Aug 23 2024
Earnings
Aug 23 2024
Earnings
Aug 23 2024
Earnings
Sales
Aug 23 2024
Earnings
Strategic Communications, Communications, Corporate Strategy, Finance, Financial Strategy, Marketing Strategy
Avalo Therapeutics News & Media
Avalo Therapeutics secures $69.4 million from warrant exercise - Investing.com
Avalo Therapeutics secures $69.4 million from warrant exerciseAvalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
WAYNE, Pa. and ROCKVILLE, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that it has received $69.4 million in gross proceeds from the full exercise of the warrants issued in a March 2024 private placement.Avalo Therapeutics to Present at Upcoming Investor Conferences
WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present at two upcoming investor conferences:Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
WAYNE, Pa. and ROCKVILLE, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced business updates and financial results for the third quarter of 2024.
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Avalo Therapeutics
Avalo Therapeutics is a global biopharmaceutical enterprise focused on the development and commercialization of products in Rare Pediatric and Orphan diseases. Cerecor is located in Rockville, Maryland.... Read More
